Serum PLGF as a potential biomarker for predicting the onset of preeclampsia

Archives of Gynecology and Obstetrics

Volumn 285, Issue 2, 2012, Pages 417-422

  Ghosh, Sanjib Kumar ^a   Raheja, Shashi ^a   Tuli, Anita ^a   Raghunandan, Chitra ^a   Agarwal, Sneh ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Angiogenic factors; ELISA; Nulliparous; Preeclampsia; Screening test; Serum PLGF

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CALCULATION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNITY WARD; NULLIPARA; OUTPATIENT DEPARTMENT; PATIENT IDENTIFICATION; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTAL GROWTH FACTOR BLOOD LEVEL; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND;

EID: 84864476309     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1960-4     Document Type: Article

References (23)

1. American College of Obstetricians and Gynecologists (2002). Diagnosis and management of preeclampsia. Practice bulletin, vol. 33.ACOG, Washington, DC
2. Sibai BM (1992) Hypertension in pregnancy. Obstet Gynecol Clin North Am 19:615-632
3. Cunningham FG Williams Obstetrics, 22nd edn, McGraw- Hill Medical Publishing Division. Hypertensive disorders in pregnancy. pp 761-808
4. Hauser S, Weich HA (1993) A heparin binding form of placenta growth factor (PLGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259-268
5. Maglione D, Guerriero V, Viglietto G, Delli Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271
6. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT (1993) Fetal liver kinase-1(Flk-1), the murine homologue of KDR exhibits high affinity binding to VEGF family of receptors. Proc Natl Acad Sci USA 90(4):7533-7537
7. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPW, Risau H, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72(6):835-846
8. Ghosh D, Sharkey AM, Dhawan L, Dhara S, Smith SK (2000) Expression VEGF and PLGF in conceptus and endometrium during implantation in the rhesus monkey. Mol Hum Reprod 6:935-941
9. Krauss T, Pauer HU, Augustin HG (2004) Prospective analysis of PLGF concentration in the plasma of women with normal pregnancies complicated by preeclampsia. Hypertens Pregnancy 23(1):101-111
10. Torry DS, Wang HS, Wang TH, Candle MR, Torry RJ (1998) Preeclampsia is associated with reduced serum levels of placenta growth factor. AMJ Obstet Gynecol 179(6 Pt 1):1539-1544
11. Levine RJ, Maynard SE, Quin C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
12. Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16:5-15
13. Su YN, Lee CN, Cheng WF, Shau WY (2001) Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 97(6):898-904
14. Jacquemyn Y, Zemtsova O (2010) Risk factors and prediction of preeclampsia. Acta Clin Belg 65(1):1-12
15. Stepan H, Jank A (2009) Angiogenic factors, their role in path-ogenesis, prediction of preeclampsia. Z Geburtshilfe Neonatol 213(3):101-105
16. Robinson CJ, Johnson DD, Chang EY, Wang W (2006) Evaluation of PLGF and sFlt-1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 195(1):255-259
17. Reuvekamp A, VelsingAarts FV, Poulina IE, Capello J (1999) Selective deficit of angiogenic growth factors characterizes pregnancies complicated by preeclampsia. Br J Obstet Gynecol 106(10):1019-1022
18. Livingston JC, Chin R, Haddad B, Mckinney ET, Ahokas R, Sibai BM (2000) Reductions of VEGF and PLGF concentrations in severe preeclampsia. Am J Obstet Gynecol 183(6):1554-1557
19. Tjoa ML, John MG, Van vugt, Monique AM (2001) Plasma placenta growth factor levels in midtrimester pregnancies. Am Coll Obstet Gynecol 98(4):600-607
20. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK (2003) Second trimester maternal serum PLGF and VEGF for predicting severe early onset preeclampsia. Obstet Gynecol 101(6):1266-1274
21. Thadani R, Mutter WP, Wolf M, Levine RJ, Taylor RN (2004) First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk factors for preeclampsia. J Clin Endocrinol Metabol 89(2):770-775
22. Park K (2005) Park's textbook of preventive and social medicine, 18th edn, Banarsidas Bhanot publishers. Screening for disease pp 119-121
23. Schmidt M, Dogan C, Birdir C, Kuhn U, Kasimir-Bauer S (2009) Placental growth factor: a predictive marker for preeclampsia? Gynakol Geburtshilfliche Rundsch 49(2):94-99